Evonik strengthens world-scale methionine production hub in U.S.

Plant is scheduled to come on stream in the second half of 2024.

February 23, 2022

2 Min Read
Evonik strengthens world-scale methionine production hub in U.S.

Evonik announced this week that it is building a methyl mercaptan plant at its site in Mobile, Alabama. Methyl mercaptan is an intermediate in the production of MetAMINO (DL-methionine) and is currently sourced from third parties. This backward integration step strengthens Evonik's site in Mobile as a global, best-in-class methionine hub for reliable and cost-optimized supply to North and South American markets. The plant is scheduled to come on stream in the second half of 2024. The investment budget of the project is approximately EUR 150 million over three years.

"The new methyl mercaptan plant in Mobile is another important step in the consistent implementation of our global methionine asset strategy," said Johann-Caspar Gammelin, head of Evonik's Nutrition & Care division. "We are securing our cash flow from the methionine business to finance our growth with system solutions in Nutrition & Care."

The core of the methionine asset strategy are the three world-class production hubs: Mobile, Antwerp (Belgium) and Singapore. Together these hubs serve the expanding global market for DL-methionine. As part of the asset strategy, the smallest methionine plant at the German site in Wesseling was discontinued in 2021. At the same time the European MetAMINO Verbund was strengthened by investment in intermediates at this site.

The global methionine production hubs in Antwerp and Singapore are already fully backward integrated. This contributes – just like the present investment in Mobile – to improved supply security and a market-leading cost position. It also facilitates future and highly efficient debottlenecking over the next years.

"In the market we stand for quality, superior supply reliability, and a high level of safety and technology standards in our assets. The backward integration in Mobile eliminates transportation of hazardous chemicals and shows our continued commitment to responsible care and business sustainability. This ultimately positions us even better as a reliable partner for our customers in the Americas," said Dr. Emmanuel Auer, head of the Animal Nutrition business line at Evonik.

The investment is also a building block of the division's sustainability strategy: it will reduce the carbon footprint of DL-methionine from Mobile by about seven percent. More than 25,000 metric tons of CO2 equivalents can be saved each year.

Methionine is used in livestock farming to feed animals healthily, efficiently, and sustainably. With its science-based approach, Evonik's Animal Nutrition business line develops products, services and system solutions that help supply a growing world population with healthy, high-quality and affordable animal protein. Animal Nutrition is part of Evonik's Nutrition & Care division and makes a significant contribution to the profitable growth of Nutrition & Care through its self-financing power.


Subscribe to Our Newsletters
Feedstuffs is the news source for animal agriculture

You May Also Like